课题基金 / 基金详情

INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES

INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES
胰岛素和胰岛素样生长因子反应
批准号：
6118889
负责人：
ALAN C MOSES
金额：
$2.98万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6118889
关键词：
androgens blood lipid body composition clinical research glucose tolerance hormone regulation /control mechanism hormone therapy human subject human therapy evaluation insulin insulin sensitivity /resistance insulinlike growth factor

项目摘要

项目成果

ALAN C MOSES的其他基金

相似基金

相关文献

中文摘要
翻译
这项研究将确定不同血型的严重胰岛素抵抗患者的胰岛素抵抗程度和胰岛素分泌的完整性，以及严重胰岛素抵抗患者在身体成分、碳水化合物耐量、卵巢雄激素分泌、血脂谱和胰岛素敏感性方面对亚急性应用胰岛素样生长因子1(3-6个月)的反应。
英文摘要
This study will determine the degree of insulin resistance and integrity of insulin secretion in subjects with various phemotypes of severe insulin resistance and the response of subjects with severe insulin resistance to subactue administration (3 to 6 months) of insulin-like growth factor 1 in regard to body composition, carbohydrate tolerance, ovarian androgen secretion, plasma lipid profiles, and insulin sensitivity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF INSULIN & INSULIN LIKE GROWTH FACTOR RESPONSES
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM
PILOT STUDY OF A NOVEL, NONINVASIVE METHOD OF BLOOD GLUCOSE MONITORING
TROGLITAZONE IN MODERATE TO SEVERE INSULIN RESISTANCE
海外基金